MTOR and neoplasm: Temsirolimus (Toricel®). Temsirolimus (Toricel®) is a mTOR inhibitor, approved for treating advanced renal cell carcinoma, 294 and treatment with this compound inhibits tumor angiogenesis, among other activities, by downregulating the synthesis of VEGF.